Yang Huang
Stock Analyst at J.P. Morgan
(4.78)
# 608
Out of 4,355 analysts
117
Total ratings
66.7%
Success rate
34.2%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $111.00 → $113.00 | $83.35 | +35.57% | 18 | Apr 30, 2026 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $77.00 → $129.00 | $82.65 | +56.08% | 12 | Mar 31, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $138.00 → $150.00 | $130.30 | +15.12% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $499.00 → $545.00 | $462.00 | +17.97% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Sell | $18.00 → $20.00 | $21.06 | -5.03% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Sell | $37.00 → $38.00 | $30.94 | +22.82% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $31.44 | +36.77% | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $60.20 | +29.57% | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $99.00 → $166.00 | $118.10 | +40.56% | 11 | Aug 27, 2025 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $16.00 → $24.00 | $13.68 | +75.44% | 2 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.00 → $37.00 | $33.34 | +10.98% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.00 → $74.00 | $54.90 | +34.79% | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 → $93.00 | $39.24 | +137.00% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84.00 → $80.00 | $38.40 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $186.00 → $183.60 | $176.80 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $1.95 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 → $64 | $17.69 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $2.17 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $8.92 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.00 | $7.50 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18.00 | $10.58 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $18.50 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $169 | $287.92 | n/a | 4 | Mar 26, 2020 |
Innovent Biologics, Inc.
Apr 30, 2026
Maintained: Buy
Price Target: $111.00 → $113.00
Current: $83.35
Upside: +35.57%
RemeGen Co., Ltd.
Mar 31, 2026
Maintained: Buy
Price Target: $77.00 → $129.00
Current: $82.65
Upside: +56.08%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $138.00 → $150.00
Current: $130.30
Upside: +15.12%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Maintained: Buy
Price Target: $499.00 → $545.00
Current: $462.00
Upside: +17.97%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Maintained: Sell
Price Target: $18.00 → $20.00
Current: $21.06
Upside: -5.03%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Maintained: Sell
Price Target: $37.00 → $38.00
Current: $30.94
Upside: +22.82%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $31.44
Upside: +36.77%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $60.20
Upside: +29.57%
Akeso, Inc.
Aug 27, 2025
Maintained: Buy
Price Target: $99.00 → $166.00
Current: $118.10
Upside: +40.56%
Genscript Biotech Corporation
Aug 21, 2025
Maintained: Buy
Price Target: $16.00 → $24.00
Current: $13.68
Upside: +75.44%
Aug 21, 2025
Maintained: Buy
Price Target: $36.00 → $37.00
Current: $33.34
Upside: +10.98%
Aug 14, 2025
Maintained: Buy
Price Target: $46.00 → $74.00
Current: $54.90
Upside: +34.79%
Aug 7, 2025
Maintained: Buy
Price Target: $52.00 → $93.00
Current: $39.24
Upside: +137.00%
May 16, 2023
Maintained: Buy
Price Target: $84.00 → $80.00
Current: $38.40
Upside: n/a
Mar 7, 2023
Maintained: Buy
Price Target: $186.00 → $183.60
Current: $176.80
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $1.95
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $217 → $64
Current: $17.69
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $2.17
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $8.92
Upside: n/a
Aug 31, 2021
Maintained: Buy
Price Target: $14.00
Current: $7.50
Upside: n/a
Aug 27, 2021
Maintained: Hold
Price Target: $18.00
Current: $10.58
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $18.50
Upside: n/a
Mar 26, 2020
Maintained: Buy
Price Target: $230 → $169
Current: $287.92
Upside: n/a